{"slideshow_credits": null, "snippet": "In its quest to defend against a hostile takeover, Allergan has pulled back the veil on the usually secretive world of mergers and acquisitions banking, publishing excerpts from emails written by senior Morgan Stanley investment bankers.", "abstract": "In its quest to defend against a hostile takeover, Allergan has pulled back the veil on the usually secretive world of mergers and acquisitions banking, publishing excerpts from emails written by senior Morgan Stanley investment bankers.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/06/16/in-battle-over-allergan-morgan-stanley-gets-in-the-crossfire/", "lead_paragraph": null, "headline": {"main": "In Battle Over Allergan, Morgan Stanley Gets in the Crossfire", "kicker": "DealBook"}, "_id": "539ef58538f0d87596d26910", "word_count": "601", "multimedia": [], "pub_date": "2014-06-16T09:46:12Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Pyott, David E I", "rank": "2"}, {"name": "persons", "value": "Hempton, John", "rank": "1"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "organizations", "value": "Morgan Stanley", "rank": "2"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "3"}, {"name": "subject", "value": "E-Mail", "rank": "2"}, {"name": "subject", "value": "Banking and Financial Institutions", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}